to BioTechniques free email alert service to receive content updates.

Cancer Biomarkers
Latest Protocols
Vendor-submitted protocol. Sponsored by Origene Technologies Published in BioTechniques Protocol Guide 2009
TissueScan is a unique qPCR array for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from thousands of well-documented cancer biopsy samples, normalized, and assembled into ready-to-use gene expression panels.
Vendor-submitted protocol. Sponsored by Origene Technologies Published in November 2007
TissueScan is a unique qPCR array of first-strand cDNA from hundreds of clinical tumor samples. It provides a fast and accurate gene expression profiling across a large number of cancer patient samples.
Vendor-submitted protocol. Published in December 2006 2007
TissueScan is a unique RT-PCR based system for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from 48 well-documented cancer biopsy samples, normalized and assembled into ready-to-use gene expression panels.
rightcontent.jsp called otherwise condition rightcontent.jsp called 11111111111111111111
Sub-categories Biomarker Validation
Search Protocols
Search our protocols for your specific technique.
[]
Submit Your Protocols
BioTechniques is always looking for author-submitted protocols related to peer-reviewed papers, so submit your protocols today to our editorial team. Suppliers or advertisers interested in publishing their protocols should also submit.
Click here for more information
Categories




In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer.

By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Bio Techniques uses cookies please go to our Cookie Policy page.